GTR Home > Tests > Search results - Glycogen storage disease, type VII

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 2020 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C0017926[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 26 tests for 1 condition in 15 labs

CGlycogen storage disease type VII

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CGlycogen Storage Disease Type VII

Lab: (AC) Atlanta Center: Medical Neurogenetics, LLC. Atlanta, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CGlycogen Storage Disease NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (15)
Total targets (14)

CPFKM Sequence Analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CPFKM Deletion/Duplication Analysis

Test targets
Methods
  • D Deletion/duplication analysis

CPFKM Comprehensive - Sequence & Deletion/Duplication Analysis

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CGlycogen Storage Disease Type VII (Tarui Disease) via the PFKM Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CMetabolic Storage Disorders Panel Sequencing, 51 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (57)
Total targets (51)

CPFKM

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CGlycogen Storage Disorders: Comprehensive Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (24)
Total targets (20)

CGlycogen Storage Disorders- Muscle: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (15)
Total targets (12)

CGlycogen storage disease VII, PFKM deficiency

Lab: Metabolic Unit, PX 1X 009 VU University Medical Center Amsterdam, Noord-Holland, Netherlands
Test targets
Methods
  • C Sequence analysis of the entire coding region

CGlycogen storage disease type 7 (sequence analysis of PFKM gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CPFKM Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CMyopathy-Rhabdomyolysis NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (60)
Total targets (24)

Showing 1 to 20 of 26 tests for 1 condition in 15 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk